InnovAge Holding Corp. INNV R2K
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. It serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 1989 and is headquartered in Denver, Colorado.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -121.6% CAGR over 5 years.
- Trading 28.4% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | INNV InnovAge Holding Corp. R2K | 7.59 | - | $1.03B | - | -8.12% | -5.88% | 6.91% | -121.62% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 144.77M | 152.57M | 157.31M | 156.31M | 173.07M | 175.35M | 177.36M | 171.22M | 167.46M | 172.54M | 182.49M | 188.90M | 193.07M | 205.14M | - | 218.14M | 221.42M | 236.10M | 239.71M | 251.94M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 177.40M | 180.13M | 184.75M | 186.88M | 190.92M |
| Gross Profit | - | - | - | - | - | - | 28.00M | 21.42M | 22.57M | 28.79M | 27.88M | 33.61M | 34.00M | 34.54M | - | 40.75M | 41.29M | 51.36M | 52.83M | 61.02M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.91M | 38.32M | 42.96M | 39.56M | 90.10M |
| Operating Income | 12.97M | -38.18M | 20.54M | -5.37M | 11.66M | 2.95M | -6.67M | -16.60M | -13.68M | -8.17M | -10.72M | -1.78M | -5.79M | -4.90M | - | -10.16M | 2.97M | 8.39M | 13.26M | -29.08M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -4.51M | 85.00K | 14.25M | 18.58M | -23.96M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.16M | 893.00K | 1.25M | 1.25M | 988.00K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -11.06M | -4.20M | 7.92M | 12.46M | -29.77M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 72.00K | 807.00K | 247.00K | 651.00K | 167.00K |
| Net Income | 8.14M | -49.65M | 9.71M | -10.51M | 7.69M | 1.32M | -2.82M | -13.07M | -9.79M | -6.63M | -10.30M | -3.45M | -5.89M | -4.93M | - | -11.38M | -785.00K | 8.02M | 10.62M | -29.46M |
| Diluted EPS | 0.06 | -0.41 | 0.08 | -0.09 | 0.06 | 0.01 | -0.02 | -0.10 | -0.07 | -0.05 | -0.08 | -0.03 | -0.04 | -0.04 | - | -0.08 | -0.01 | 0.06 | 0.08 | -0.22 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Revenue | 567.19M | - | 698.64M | 688.09M | 763.86M | 853.70M |
| Cost of Revenue | - | - | 563.27M | 586.80M | 631.79M | 700.06M |
| Gross Profit | - | - | 135.37M | 101.29M | 132.06M | 153.64M |
| Operating Expenses | - | - | 139.78M | 150.68M | 155.24M | 169.78M |
| Operating Income | 50.93M | - | -4.41M | -49.40M | -23.18M | -16.15M |
| EBITDA | - | - | 9.21M | -33.85M | 1.15M | -9.90M |
| Interest Expense | - | - | 2.53M | 1.52M | 4.02M | 4.61M |
| Pretax Income | - | - | -7.24M | -50.79M | -21.82M | -34.03M |
| Tax Provision | - | - | 723.00K | -7.24M | 1.40M | 1.32M |
| Net Income | 26.28M | - | -6.52M | -40.67M | -21.34M | -30.31M |
| Diluted EPS | 0.19 | -0.36 | -0.05 | -0.30 | -0.16 | - |
Compounded Sales Growth
| 5 Years: | 6.91% |
| 1 Year: | 15.50% |
Compounded Profit Growth
| 5 Years: | -121.62% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +85.57% |
| 6 Months: | +42.67% |
| 3 Months: | -15.29% |
| 1 Month: | -5.95% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2019 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 409.63M | - | 555.60M | 567.36M | 547.66M | 526.85M |
| Current Assets | - | - | - | - | 240.96M | 215.23M | 173.14M | 176.11M |
| Cash & Equivalents | 9.00M | - | 112.90M | - | 184.43M | 127.25M | 56.95M | 64.13M |
| Inventory | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | 35.91M | 24.34M | 48.11M | 36.37M |
| Total Liabilities | - | - | 301.88M | - | 201.85M | 252.56M | 247.85M | 263.94M |
| Current Liabilities | - | - | 76.63M | - | 105.31M | 148.45M | 138.60M | 164.81M |
| Long Term Debt | - | - | 210.43M | - | 68.21M | 64.84M | 61.48M | 57.46M |
| Total Debt | - | - | - | - | 84.81M | 108.83M | 113.03M | 101.08M |
| Total Equity | - | 81.44M | 101.02M | - | 332.36M | 296.30M | 269.26M | 234.97M |
| Shares Outstanding | - | - | - | - | 135.53M | 135.64M | 136.15M | 136.90M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 43.83M | - | 27.30M | 20.24M | -36.90M | 32.87M |
| Investing Cash Flow | -11.69M | - | -40.24M | -69.52M | -26.37M | -5.55M |
| Financing Cash Flow | 21.23M | - | -6.32M | -7.90M | -7.03M | -19.08M |
| Capital Expenditure | -11.84M | - | -38.24M | -23.35M | -7.91M | -6.26M |
| Free Cash Flow | 31.98M | - | -10.94M | -3.12M | -44.81M | 26.60M |
| Net Change in Cash | - | - | -19.25M | -57.18M | -70.31M | 8.23M |
| Share Buybacks | - | 77.60M | - | - | - | - |
| Dividends Paid | - | 9.50M | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | 19.4% | 14.7% | 17.3% | 18.0% |
| Operating Margin % | 9.0% | - | -0.6% | -7.2% | -3.0% | -1.9% |
| Net Margin % | 4.6% | - | -0.9% | -5.9% | -2.8% | -3.6% |
| ROE % | 26.0% | - | -2.0% | -13.7% | -7.9% | -12.9% |
| ROCE % | 15.3% | - | -1.0% | -11.8% | -5.7% | -4.5% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management, Inc. | 4.52% | 6.13M | $46.55M |
| 2 | Blackrock Inc. | 0.92% | 1.25M | $9.47M |
| 3 | Coliseum Capital Management, Llc | 0.82% | 1.11M | $8.46M |
| 4 | Vanguard Capital Management LLC | 0.65% | 877.14K | $6.66M |
| 5 | Geode Capital Management, LLC | 0.42% | 573.42K | $4.35M |
| 6 | Hillsdale Investment Management Inc. | 0.39% | 529.98K | $4.02M |
| 7 | State Street Corporation | 0.32% | 431.43K | $3.27M |
| 8 | Arrowstreet Capital, Limited Partnership | 0.31% | 417.54K | $3.17M |
| 9 | Renaissance Technologies, LLC | 0.27% | 370.82K | $2.81M |
| 10 | O'Shaughnessy Asset Management LLC | 0.20% | 272.54K | $2.07M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for INNV